Franklin Resources Portfolio holdings
Franklin Resources, Inc., commonly known as Franklin Templeton, was founded in 1947 by Rupert H. Johnson, Sr., and is headquartered in San Mateo, California, operating as a global investment management firm managing hundreds of billions in assets. The company offers a wide range of investment products, including mutual funds, ETFs, fixed-income portfolios, and alternative investments, serving individual investors, financial advisors, and institutions across over 150 countries. Known for its acquisition-driven growth—such as the 1992 purchase of Templeton Investments and the 2020 addition of Legg Mason—Franklin Templeton combines diverse strategies under a single brand, emphasizing both active management and income-focused solutions like its flagship Franklin Income Fund. With a reputation for adaptability and a client-centric approach, it remains a major player in the global asset management industry.
Top Buys
| 1 |
Shell
SHEL
|
$441M |
| 2 |
ATVI
Activision Blizzard Inc.
ATVI
|
$438M |
| 3 |
Texas Instruments
TXN
|
$424M |
| 4 |
Humana
HUM
|
$390M |
| 5 |
AstraZeneca
AZN
|
$350M |
Top Sells
| 1 |
Merck
MRK
|
$1.3B |
| 2 |
Pfizer
PFE
|
$921M |
| 3 |
AbbVie
ABBV
|
$916M |
| 4 |
Coca-Cola
KO
|
$884M |
| 5 |
Chevron
CVX
|
$770M |
Sector Composition
| 1 | Technology | 23.34% |
| 2 | Healthcare | 16.48% |
| 3 | Financials | 10.07% |
| 4 | Consumer Discretionary | 8.66% |
| 5 | Industrials | 8.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SPPI
2151
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $161K | ﹤0.01% |
125,286
-788
| -0.6% | -$1.01K |
|
2152
Grifois
GRFS
$6.53B
| $161K | ﹤0.01% |
13,822
+179
| +1% | +$2.09K |
|
2153
Gerdau
GGB
$6.05B
| $161K | ﹤0.01% |
25,074
+489
| +2% | +$3.14K |
|
2154
Cemex
CX
$13.3B
| $161K | ﹤0.01% |
30,441
+775
| +3% | +$4.1K |
|
2155
Zillow
ZG
$19.6B
| $158K | ﹤0.01% |
3,269
-104
| -3% | -$5.03K |
|
2156
BlackLine
BL
$3.26B
| $158K | ﹤0.01% |
2,161
-725
| -25% | -$53K |
|
2157
Q32 Bio
QTTB
$20.9M
| $157K | ﹤0.01% |
51,579
| – | – |
|
2158
Aegon
AEG
$12.3B
| $157K | ﹤0.01% |
29,505
+1,903
| +7% | +$10.1K |
|
|
EQC.PRD
2159
DELISTED
Equity Commonwealth 6 1/2% Series D Cumulative Convertible Preferred Shares
EQC.PRD
| $156K | ﹤0.01% |
+5,645
| New | +$156K |
|
2160
SFL Corp
SFL
$1.08B
| $156K | ﹤0.01% |
15,279
| – | – |
|
2161
Theravance Biopharma
TBPH
$691M
| $155K | ﹤0.01% |
+16,260
| New | +$155K |
|
2162
Black Stone Minerals
BSM
$2.57B
| $154K | ﹤0.01% |
11,419
| – | – |
|
2163
Uranium Energy
UEC
$5.11B
| $152K | ﹤0.01% |
33,034
-798
| -2% | -$3.67K |
|
2164
Riskified
RSKD
$712M
| $152K | ﹤0.01% |
+25,149
| New | +$152K |
|
2165
Ironwood Pharmaceuticals
IRWD
$201M
| $151K | ﹤0.01% |
12,031
+1,933
| +19% | +$24.3K |
|
2166
SiriusXM
SIRI
$7.92B
| $147K | ﹤0.01% |
22,198
-577
| -3% | -$3.84K |
|
2167
Cohen & Steers Closed End Opportunity Fund
FOF
$361M
| $146K | ﹤0.01% |
11,324
-3,776
| -25% | -$48.7K |
|
2168
Mizuho Financial
MFG
$79.5B
| $146K | ﹤0.01% |
56,825
-9,204
| -14% | -$23.6K |
|
2169
Dynavax Technologies
DVAX
$1.19B
| $145K | ﹤0.01% |
13,349
-4,808
| -26% | -$52.2K |
|
2170
ClearBridge Dividend Strategy ESG ETF
YLDE
$115M
| $142K | ﹤0.01% |
3,342
-503
| -13% | -$21.4K |
|
2171
VTEX
VTEX
$728M
| $141K | ﹤0.01% |
+22,988
| New | +$141K |
|
|
DISCA
2172
DELISTED
Discovery, Inc. Series A Common Stock
DISCA
| $141K | ﹤0.01% |
5,683
-300
| -5% | -$7.44K |
|
2173
iShares US Pharmaceuticals ETF
IHE
$581M
| $139K | ﹤0.01% |
716
| – | – |
|
2174
Opendoor
OPEN
$3.78B
| $139K | ﹤0.01% |
16,076
-1,197
| -7% | -$10.4K |
|
2175
Arbutus Biopharma
ABUS
$753M
| $137K | ﹤0.01% |
+45,900
| New | +$137K |
|